Results 71 to 80 of about 59,185 (303)
Herpes zoster subunit vaccine for the prevention of herpes zoster
American Journal of Health-System Pharmacy, 2018 Published literature on the efficacy and safety of the herpes zoster (HZ) subunit vaccine (HZ/su vaccine) in reducing the risks of HZ and postherpetic neuralgia (PHN) in adults 50 years of age and older, as well as the vaccine's properties and efficacy relative to live attenuated vaccine, is reviewed.HZ/su vaccine (Shingrix, GlaxoSmithKline) is a ...
Symoniak, Melanie +3 more
openaire +4 more sources
Effect of herpes zoster vaccine and antiviral treatment on risk of ischemic stroke
Neurology, 2020 Objective To determine whether increased risk of acute ischemic stroke (AIS) following herpes zoster (HZ) might be modified by the status of zoster vaccine live (ZVL) vaccination and antiviral treatment following HZ.
Quanhe Yang +5 more
semanticscholar +1 more source
PLoS ONE, 2021 ObjectivesComprehensive cost-effectiveness analyses of introducing varicella and/or herpes zoster vaccination in the Swedish national vaccination programme.DesignCost-effectiveness analyses based on epidemiological results from a specifically developed ...
Ellen Wolff +5 more
doaj +1 more source
No evidence of family history as a risk factor for herpes zoster in patients with post-herpetic neuralgia [PDF]
, 2010 Little is known about reactivation of latent varicella zoster virus as herpes zoster in individuals with no underlying immunosuppression. Risk factors include age, sex, ethnicity, exogenous boosting of immunity from varicella contacts, underlying cell ...
Boccia, Mt +5 more
core +1 more source
Herpes Zoster After Yellow Fever Vaccination [PDF]
Journal of Travel Medicine, 2007 An immunocompetent 64-year-old women presented with brachial herpes zoster (HZ) infection 3 days after vaccination against yellow fever (YF). The lesions disappeared after antiviral treatment. There are very few reports of a possible association between YF vaccination and HZ infection.
Jose-Maria, Bayas +2 more
openaire +2 more sources
Herpes zoster vaccination in systemic lupus erythematosus: the current status
Human Vaccines & Immunotherapeutics, 2019 Among the inflammatory rheumatic diseases, SLE is associated with the highest risk of herpes zoster reactivation relative to age. The reported incidence of herpes zoster infection in SLE ranges from 6.4 to 91.4/1000 patient-years, with main risk factors ...
Chi Chiu Mok
doaj +1 more source
Vaccines for prophylaxis of viral infections in patients with hematological malignancies. [PDF]
, 2011 Viral infections cause significant morbidity and mortality in patients with hematological malignancies. It remains uncertain whether viral vaccinations in these patients are supported by good evidence.
Chan, GC +4 more
core +1 more source
Annals of the Rheumatic Diseases, 2020 Herpes zoster (HZ) incidence is higher in patients with rheumatoid arthritis (RA) compared with the general population,1 and it may be further increased with disease-modifying antirheumatic drugs (DMARDs).2 Tofacitinib is an oral Janus kinase inhibitor ...
K. Winthrop +9 more
semanticscholar +1 more source
Advanced Science, EarlyView.This study designs a novel mRNA‐LNP vaccine targeting VZV glycoprotein E (gE) for herpes zoster via an AI‐assisted pipeline. Validated in mice and rhesus macaques, the mRNA‐LNP vaccine shows strong humoral and cellular immune responses, with CD4+ T‐cell responses more effective and durable than Shingrix, offering a promising prophylactic option ...
Kai Dong +6 more
wiley +1 more source
Swiss Medical Weekly, 2021 INTRODUCTION: Herpes zoster is the common reactivation of latent varicella zoster virus infection and is associated with substantial morbidity and costs.
Leonard D. Bongers +3 more
doaj +1 more source